The New Zealand Clinical Oncology Next Generation Sequencing market was valued at USD 4.12 Million in 2024 and is expected to reach USD 14.83 Million by 2032, growing at a CAGR of 17.4% (2025-2032). Get insights on trends, segmentation, and key playe